CJC-1295 with DAC 5MG

$100.00

CJC-1295 with DAC 5MG is a long-acting growth hormone-releasing hormone (GHRH) analogue supplied in a 03ML vial for laboratory and analytical research. The DAC modification allows the peptide to bind to circulating albumin, which has been studied for extending its biological half-life and supporting prolonged investigation of GH and IGF-1 signaling.

Description

CJC-1295 with DAC 5MG

CJC-1295 with DAC is a synthetic GHRH analogue designed with a Drug Affinity Complex (DAC). This modification enables covalent binding to endogenous albumin, producing a substantially longer circulating half-life than shorter-acting GHRH analogues. Research has examined its effects on growth hormone secretion, IGF-1 production, and pituitary endocrine signaling.

Product Details

Product: CJC-1295 with DAC
Strength: 5MG
Volume: 03ML
SKU: SP111
Price: $100
Category: Body Composition & Growth Hormone Support
Use: Research Use Only

About CJC-1295 with DAC

CJC-1295 with DAC has been investigated as a long-acting GHRH analogue. Human research reported prolonged increases in GH and IGF-1 after administration, with an estimated half-life of approximately 6–8 days. Research also found that pulsatile GH secretion was preserved despite prolonged GHRH stimulation.

Research Areas of Interest

Growth hormone-releasing pathways
GH secretion research
IGF-1 signaling
Pituitary endocrine signaling
GHRH receptor research
Albumin-binding peptide research
Long-acting peptide pharmacokinetics
Metabolic and body-composition related pathways

Research Use Statement

CJC-1295 with DAC 5MG is intended strictly for laboratory, analytical, and research purposes only. It is not for human or animal consumption and is not intended for medical, diagnostic, or therapeutic use.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 with DAC 5MG”

Your email address will not be published. Required fields are marked *